Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News


eurohealthobservatory.who.int > news-room > events > item > 09/22/2026 > default-calendar > promoting-affordable-access-to-new-medicines-a-state-of-health-in-the-eu-webinar

Promoting affordable access to new medicines: a State of Health in the EU webinar

9+ hour ago   (115+ words) Access to medicines is under pressure across the EU, as rising prices for new therapies and growing demand test the limits of public budgets. Between 2020 and 2025, Member States implemented wide-ranging reforms to expand coverage, reduce out-of-pocket costs, and sustain innovation....


cardiacwire.com > the-queen-arrives-with-ai-ecg-for-urgent-mi

The Queen Arrives With AI-ECG for Urgent MI

19+ hour, 31+ min ago   (287+ words) Many heart attack patients still miss the window for life-saving treatment because of diagnostic delays, but that’s changing with the FDA’s De Novo authorization of Powerful Medical’s Queen of Hearts AI-ECG model that detects STEMI and its harder-to-spot equivalents. As…...


healthexec.com > topics > healthcare-management > mergers-and-acquisitions > report-ge-healthcare-buy-sofie-biosciences-1-billion-part-pharmaceutical-diagnostics-expansion

Report: GE HealthCare to buy Sofie Biosciences for $1 billion as part of pharmaceutical diagnostics expansion

17+ hour, 51+ min ago   (324+ words) GE HealthCare’s contrast media manufacturing site in Cork, Ireland. GE HealthCare is looking to buy Sofie Biosciences, a private-equity backed business that develops radiopharmaceuticals used for cancer diagnostics and treatment. The deal, which could be announced next week, is said…...


plexusdx.com > blogs > learn > switch-from-trava-to-plexusdx

Switch From Trava to PlexusDx: Evidence Gaps and What to Verify

23+ hour, 16+ min ago   (1428+ words) Shop all 5 Weight Loss programs → Compare GLP-1 providers → Start Weight Loss intake → Shop all 5 Longevity programs → Start Longevity intake → GLP-1 & Peptide Pathways Food Sensitivity & Allergies Diet & Weight Loss Cognition and Brain Health Genetic Test Stress and Mental Health Genetic Test…...


sentinelnews.com.au > health-wellbeing > trial-results-offers-new-hope-for-heart-patients

Trial results offers new hope for heart patients - The Sentinel News

18+ hour, 21+ min ago   (68+ words) Trial results offers new hope for heart patients sentinelnews.com.au Trial results offers new hope for heart patients Ramping falls to six-year low The rise of anti-vaccine activism and the fall of child immunisation Sardinemaxxing is no fishy fad…...


bdaily.co.uk > articles > 09/13/2026 > pmm-welcomes-nine-new-trainees

PM+M welcomes nine new trainees

20+ hour, 33+ min ago   (236+ words) Published by Bdaily Bdaily Business News on 13 Sep 2026 Blackburn and Bury-based accountancy, business advisory and financial planning group PM+M has welcomed nine trainees as part of its latest early-career intake. Abdur-Rahman Chati and Aidan Stokes have joined its accounting…...


stockstotrade.com > news > edgewisetherapeuticsinc-ewtx-news-2026_09_13

Edgewise Therapeutics Jumps As EDG-7500 Data Fuels Bullish Target Hike

1+ day, 2+ hour ago   (395+ words) Edgewise Therapeutics Inc. stocks have been trading up by 7.32 percent following highly positive clinical trial advancement news. What Traders Need To Know JPMorgan lifted its price target to $60 from $53 and kept an Overweight rating after updating its model following Edgewise…...


medpagetoday.com > opinion > what-we-heard > 122972

Opinion | 'A Real-but-Vanilla Commercial Dispute': What We Heard This Week

21+ hour, 45+ min ago   (323+ words) — Quotable quotes heard by MedPage Today's reporters "The underlying case is a real-but-vanilla commercial dispute." -- Christopher Robertson, JD, PhD, of Boston University, discussing a medical software company's lawsuit against a former collaboratoropens in a new tab or window, who helped…...


antikor.info > en > articles > 862687-osobnjak_za_300_tysjach_dollarov_i_laboratorija_dlja_svoih_gosleksluhbu_likvidirovali_i_sozdali_novyj_organ

A $300,000 mansion and a lab for???their own???: State Medicines Service liquidated and new agency created

1+ day, 6+ hour ago   (458+ words) A $300,000 mansion and a lab for “their own”: State Medicines Service liquidated and new agency created АНТИКОР - A $300,000 mansion and a lab for?their own?: State Medicines Service liquidated and new agency created This is reported by Glavcom. The previous…...